- Home
- MEDP vs RVMD Comparison
MEDP vs RVMD Comparison
Compare MEDP & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- RVMD
- Stock Information
- Founded
- MEDP 1992
- RVMD 2014
- Country
- MEDP United States
- RVMD United States
- Employees
- MEDP N/A
- RVMD N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MEDP Health Care
- RVMD Health Care
- Exchange
- MEDP Nasdaq
- RVMD Nasdaq
- Market Cap
- MEDP 8.5B
- RVMD 7.4B
- IPO Year
- MEDP 2016
- RVMD 2020
- Fundamental
- Price
- MEDP $309.36
- RVMD $39.66
- Analyst Decision
- MEDP Hold
- RVMD Strong Buy
- Analyst Count
- MEDP 10
- RVMD 12
- Target Price
- MEDP $343.22
- RVMD $68.67
- AVG Volume (30 Days)
- MEDP 344.5K
- RVMD 1.7M
- Earning Date
- MEDP 07-21-2025
- RVMD 08-06-2025
- Dividend Yield
- MEDP N/A
- RVMD N/A
- EPS Growth
- MEDP 33.36
- RVMD N/A
- EPS
- MEDP 13.09
- RVMD N/A
- Revenue
- MEDP $2,156,580,000.00
- RVMD N/A
- Revenue This Year
- MEDP $5.64
- RVMD N/A
- Revenue Next Year
- MEDP $3.32
- RVMD $241.39
- P/E Ratio
- MEDP $23.59
- RVMD N/A
- Revenue Growth
- MEDP 9.87
- RVMD N/A
- 52 Week Low
- MEDP $250.05
- RVMD $29.17
- 52 Week High
- MEDP $459.77
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- MEDP 55.79
- RVMD 49.08
- Support Level
- MEDP $294.07
- RVMD $38.57
- Resistance Level
- MEDP $304.69
- RVMD $42.40
- Average True Range (ATR)
- MEDP 9.68
- RVMD 1.38
- MACD
- MEDP 0.72
- RVMD -0.16
- Stochastic Oscillator
- MEDP 66.62
- RVMD 28.46
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.